Navigation Links
Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™
Date:8/31/2011

Pty Ltd
Level 9, 278 Collins Street, Melbourne, 3000, Australia
www.hatchtech.com.au

About DeOvo™Despite its prevalence and high cost to the community, there have been few major advances in controlling head lice infestation in recent years. Most pediculicide products have little ovicidal activity and require two treatments (approximately 7 days apart), with the second application designed to treat those lice which have hatched from eggs that survive the first treatment. Non-compliance with this regimen and the difficulty in choosing the optimal time for the second application, are major difficulties in using these products. Hatchtech's DeOvo™, a topical formulation of a known metalloprotease inhibitor, has shown both ovicidal and lousicidal activity and offers the potential for a more effective treatment following a single application.

About PediculosisIt is estimated that 6-12 million people, in the United States, mainly children aged 3-12, are infested each year with head lice (Pediculus humanus capitis). The direct cost of treatment is estimated at several hundreds of millions of dollars. Added to this direct economic burden are the indirect costs including missed days from school, lost work productivity by parents who stay home to treat their children and costs borne by the school itself in trying to control or prevent this problem. The total costs have been estimated to be 1billion USD in the US alone.


'/>"/>

SOURCE Hatchtech Pty Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Belgium , Sept. 1, 2015 ... company focused on developing blood-based diagnostic tests for a broad ... its Chief Executive Officer, Cameron Reynolds , is scheduled ... Conference, which is being held September 9-10, 2015 in ... all day on September 10. Wells Fargo ...
(Date:9/1/2015)... BAKERSFIELD, Calif. , Sept. 1, 2015 /PRNewswire/ ... Chronic Care Management (CCM) and Drug Adherence m ... monitoring help automate the process of non face-to-face ... "With this new release of our apps, ... care management services along with our ONCHIT certified ...
(Date:9/1/2015)... , Sept. 1, 2015   Ivenix Inc. ... infusion management system, closed on a $42M round ... Healthcare Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, ... in the round. This financing will support the ... market. Leerink Partners LLC acted as the exclusive ...
Breaking Medicine Technology:VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3
... , , ...  (AIM: CRW.L), the market leader in automated revenue integrity ... new product and its first customer. , Supplies ... manage and optimize reimbursement for chargeable supplies. It does this ...
... , , JERUSALEM , ... privately held biopharma company, announced today that it has granted Novartis ... the Company,s Transient Permeability Enhancer (TPE) technology for use with certain ... Novartis. In a separate but related agreement, the MPM Bio ...
Cached Medicine Technology:Craneware's New Product Reduces Supply Chain Revenue Leakage 2Craneware's New Product Reduces Supply Chain Revenue Leakage 3Craneware's New Product Reduces Supply Chain Revenue Leakage 4Chiasma Grants Option to License Transient Permeability Enhancer (TPE) Technology for Small Molecule Products 2Chiasma Grants Option to License Transient Permeability Enhancer (TPE) Technology for Small Molecule Products 3
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... law firms and government entities, announced today that it has hired Scott Sanderson, ... Consultant. In this capacity, Sanderson will be responsible for establishing and managing ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , ... facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of a collection of fundraising events ... to raise awareness of the FSH Society and further FSHD research. , ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Kit is now available. With the Connectivity Kit, EasySampler data is ... jacketed lab reactor control experiment, on a touchscreen platform. , EasySampler fully ...
(Date:9/1/2015)... ... September 01, 2015 , ... The ... to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland Street, Indianapolis, ... be attending from across the country. All specialties will be represented. Attendees will ...
(Date:9/1/2015)... ... ... Dr. Trace Curry successfully placed one of the first ORBERA™ Intra-gastric Balloons ... FDA has approved two intra-gastric balloons, the ORBERA ™ Managed Weight Loss System ... weight loss procedures available to Americans. , Dr. Curry, medical director at ...
Breaking Medicine News(10 mins):Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2
... Management (AIM), an,operating subsidiary of WellPoint, Inc. (NYSE: ... and technology company with health plan clients,representing over ... an,agreement to provide diagnostic imaging management services for ... Under this agreement, AIM will administer Blue Cross ...
... Jan. 29 Z Trim Holdings, Inc.,(OTC Bulletin ... Technology Ingredients (WTI), a specialty ingredients company to ... Trim ingredients will be,represented to the meat industry ... in Jefferson, Georgia, where they maintain a state-of-the-art,46,000 ...
... HOUSTON, Jan. 29 RediClinic LLC today announced ... Blue Cross and Blue,Shield of Texas to include ... RediClinic located in Texas an in-network provider for ... in six H-E-B stores in,the Austin area and ...
... expand oncology pipeline, and explore potential for other ... Biomed International Inc. ("Genyous") announced today that it ... agreement with multiple closings. Under the terms ... three tranches: $12 million before March 31, 2009, ...
... Responders Leading the Charge of Cooling Therapy for ... (NYSE Alternext US: CXM) and its operating unit ... of the country,s first responders leading the charge ... patients. Newly emerging protocols recommend that cardiac ...
... PFOS, PFOA as additives is being phased out, researchers ... known as perfluorinated chemicals, which are pervasive in food ... may delay pregnancy, a new study suggests. , These ... because of their toxic effects, and are expected to ...
Cached Medicine News:Health News:American Imaging Management to Partner with Blue Cross of Idaho 2Health News:Z Trim to Be Distributed to Meat and Poultry Industries by World Technology Ingredients 2Health News:Z Trim to Be Distributed to Meat and Poultry Industries by World Technology Ingredients 3Health News:Z Trim to Be Distributed to Meat and Poultry Industries by World Technology Ingredients 4Health News:RediClinic Locations in Austin Added as Blue Cross and Blue Shield of Texas Network Providers 2Health News:Genyous Biomed Announces Private Placement Financing 2Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 2Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 3Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 4Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 5Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 6Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 7Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 8Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 9Health News:Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia 10Health News:Common Chemicals May Delay Pregnancy 2Health News:Common Chemicals May Delay Pregnancy 3
Titanium hemi arthroplasty implant for degenerative and post-traumatic arthritis of first metatarsophalangeal joint....
... Cranial Nerve Electrodes provide direct cranial ... Their patented circumferential design provides sensitive ... high-quality, stable real-time recordings. This unique ... during the removal of acoustic neuromas, ...
... of Ad-Techs products, our Sphenoidal Electrodes are manufactured ... available in stainless steel or platinum and feature ... (70 mm) long, 21 gauge (0.83 mm) introducing ... as kits or sets. You can also choose ...
... Stellate Harmonie workstation is a medical device ... high quality video capability, and archiving demands ... review functions A framework that helps organize ... of data A centralized database and powerful ...
Medicine Products: